Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and preliminary efficacy of autologous
adipose-derived mesenchymal stem cells (ADMSCs) treatment for patients with primary
osteoarthritis knee. Three intra-articular injections of autologous ADMSCs will be performed
to subjects at a weekly interval.